+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Microsomal triglyceride transfer protein and nonalcoholic fatty liver disease



Microsomal triglyceride transfer protein and nonalcoholic fatty liver disease



Expert Review of Gastroenterology and Hepatology 5(2): 245-251



Nonalcoholic fatty liver disease is currently one of the most common forms of liver disease, covering cases from simple steatosis without inflammation, to cases of steatohepatitis and fibrosis, and may lead to liver cirrhosis and hepatocellular carcinoma. The pathophysiology of nonalcoholic fatty liver disease is based on multiple events; changes in the secretion of lipoproteins can lead to steatosis. Liver lipid secretion is mediated by apoB100 and microsomal triglyceride transfer protein (MTP). The pharmacological suppression of MTP is suggested as a possible treatment for hyperlipidemia, although the upregulation of this protein can be a treatment for nonalcoholic steatohepatitis.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 054379537

Download citation: RISBibTeXText

PMID: 21476919

DOI: 10.1586/egh.11.22


Related references

Association of polymorphisms in glutamate-cysteine ligase catalytic subunit and microsomal triglyceride transfer protein genes with nonalcoholic fatty liver disease. Dna and Cell Biology 30(8): 569-575, 2011

Polymorphisms of microsomal triglyceride transfer protein gene and phosphatidylethanolamine N-methyltransferase gene in alcoholic and nonalcoholic fatty liver disease in Koreans. European Journal of Gastroenterology and Hepatology 21(6): 667-672, 2009

Association of polymorphisms of glutamate-cystein ligase and microsomal triglyceride transfer protein genes in non-alcoholic fatty liver disease. Journal of Gastroenterology and Hepatology 25(2): 357-361, 2010

Prevention of hepatic fibrosis with liver microsomal triglyceride transfer protein deletion in liver fatty acid binding protein null mice. Hepatology 65(3): 836-852, 2017

Expression and methylation of microsomal triglyceride transfer protein and acetyl-CoA carboxylase are associated with fatty liver syndrome in chicken. Poultry Science 95(6): 1387-1395, 2016

Co-translational degradation of apolipoprotein B100 by the proteasome is prevented by microsomal triglyceride transfer protein. Synchronized translation studies on HepG2 cells treated with an inhibitor of microsomal triglyceride transfer protein. Journal of Biological Chemistry 272(33): 20435-20442, 1997

Coordinate transcriptional repression of liver fatty acid-binding protein and microsomal triglyceride transfer protein blocks hepatic very low density lipoprotein secretion without hepatosteatosis. Journal of Biological Chemistry 281(44): 33066-33077, 2006

Etiology of fatty liver in dairy cattle: effects of nutritional and hormonal status on hepatic microsomal triglyceride transfer protein. Journal of Dairy Science 83(10): 2239-2251, 2000

Involvement of microsomal triglyceride transfer protein in nonalcoholic steatohepatitis in novel spontaneous mouse model. Journal of Hepatology 52(6): 903-912, 2010

Triglyceride and phospholipid binding to the bovine liver microsomal triglyceride transfer protein. FASEB Journal 7(7): A1268, 1993

Functional genetic polymorphisms of microsomal triglyceride transfer protein and manganase-SOD in nonalcoholic steatohepatitis and primary biliary cirrhosis. Journal of Hepatology 40(Suppl 1): 175, 2004

Polymorphism in microsomal triglyceride transfer protein: a link between liver disease and atherogenic postprandial lipid profile in NASH?. Hepatology 45(5): 1097-1107, 2007

Nonalcoholic steatohepatitis (NASH) in ob/ob mice treated with yo jyo hen shi ko (YHK): effects on peroxisome proliferator-activated receptors (PPARs) and microsomal triglyceride transfer protein (MTP). Digestive Diseases and Sciences 52(12): 3448-3454, 2007

Induction of microsomal triglyceride transfer protein expression is a candidate mechanism by which ezetimibe therapy might exert beneficial effects in patients with nonalcoholic steatohepatitis. Journal of Gastroenterology 46(3): 415-6; Author Reply 417, 2011

Hepatic triglyceride synthesis and nonalcoholic fatty liver disease. Current Opinion in Lipidology 19(3): 295-300, 2008